QIF-T0099
criticalConsumer-sensor-to-BCI kill chain escalation (pre-implant reconnaissance and cognitive priming via consumer devices)
Tier 5 — Theoretical (Modeled / Simulated)
Legacy status: THEORETICAL
This capstone technique documents the full S-domain-to-BCI escalation kill chain: how consumer sensor exploitation serves as reconnaissance and preparation for subsequent BCI attacks. The chain proceeds in phases: (1) RECON — Consumer sensors (phone, watch, earbuds) establish behavioral baseline: gait patterns (T0088), cardiac signature (T0093), neurological profile (T0089), cognitive patterns (T0085 if VR/AR). (2) FINGERPRINT — Multi-modal biometric fusion (T0096) creates persistent identity profile. (3) PROFILE — Cross-device correlation (T0097) builds comprehensive health/cognitive baseline. (4) ESCALATE — When the target receives a BCI (medical implant, consumer neural interface), the attacker's pre-existing profile informs: optimal attack parameters for neural injection (calibrated to individual's neural baseline), personalized evasion of anomaly detection (trained on their 'normal'), and targeted cognitive exploitation (leveraging known cognitive vulnerabilities). The S-domain reconnaissance makes BCI attacks more effective, more targeted, and harder to detect. This technique represents the strategic justification for the entire S-domain: consumer sensors are the advance scout for future BCI exploitation.
Technique Details
- Tactic
- QIF-S.CH
- Status
- THEORETICAL
- Bands
- S1, S2, S3, I0, N1, N7
✚ Therapeutic Application
Full S-domain-to-BCI escalation: consumer sensor reconnaissance builds behavioral/physiological/cognitive baseline that informs and optimizes subsequent BCI attack parameters
Clinical Analog
Pre-surgical neurological baseline assessment for BCI implant calibration
Treats
- BCI implant pre-surgical planning (behavioral baseline)
- neural interface calibration (cognitive baseline)
- personalized neuroprosthetic fitting
- rehabilitation baseline assessment
Neural Impact
6 of 7 neural bands affected
Drag to rotate. Click a region to learn more.
Click or hover over a glowing region to see the attack techniques targeting it and their severity.
DSM-5-TR Diagnostic Mappings
Diagnostic category references for threat modeling, not diagnostic claims.
Pathway: N7 (PFC/M1) → executive function; I0 (electrode-tissue boundary) → measurement
Following Poldrack (2006), brain region disruption does not uniquely predict psychiatric outcomes.
Scoring
NISS:1.1/BI:N/CR:H/CD:H/CV:I/RV:T/NP:T CVSS:4.0/AV:N/AC:H/AT:P/PR:L/UI:N/VC:H/VI:H/VA:L/SC:H/SI:H/SA:L Governance
Neurorights at Risk
This technique threatens 6 of the 4 proposed neurorights (Ienca & Andorno, 2017).
FDORA §3305 Compliance
- ! CVSS cannot express neural-specific impacts
- ! No FDA pathway for consumer sensor exploitation
- ! Threat not yet in regulatory threat catalogs
Population Vulnerability
CRB vulnerability adjustment (γ=0.30) accounts for age, diagnosis severity, consent capacity, and device dependency.
| Population | NISS Base | Adjusted | Severity | Delta |
|---|---|---|---|---|
| Adult (Default) | 4.7 | 4.7 | Medium | - |
| Child (10yr) + ADHD | 4.7 | 5.5 | Medium | +0.83 |
| Adult with ALS | 4.7 | 5.5 | Medium | +0.76 |
Validation Status
Theoretical / Not yet validated. This technique has not been independently tested. See the validation dashboard for what has been tested.